2026-07-03 Putting Data into Practice Using Oral SERDs Education Alert Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data 0.50 CME / CE / ABIM MOC Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases? Learn More 92.74% of Pharmacists like you who have participated in similar programs believed the program would impact patient outcomes. 回上一頁
